PM
ALDX icon

Prosight Management’s Aldeyra Therapeutics ALDX Stock Holding History

Prosight Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-149,511
Closed -$1.25M – 43
2023
Q2 		$1.25M Sell
149,511
-233,936
-61% -$2.3M 0.37% 32
2023
Q1 		$3.81M Sell
383,447
-475,262
-55% -$3.36M 1.81% 23
2022
Q4 		$5.98M Sell
858,709
-352,091
-29% -$2.01M 3.26% 11
2022
Q3 		$6.47M Sell
1,210,800
-775,083
-39% -$4.65M 3.46% 10
2022
Q2 		$7.92M Buy
1,985,883
+585,644
+42% +$2.01M 6.24% 6
2022
Q1 		$6.22M Buy
1,400,239
+244,939
+21% +$976K 4.02% 8
2021
Q4 		$4.62M Buy
1,155,300
+420,300
+57% +$3.21M 2.77% 14
2021
Q3 		$6.45M Buy
735,000
+139,761
+23% +$1.28M 3.55% 8
2021
Q2 		$6.74M Buy
595,239
+121,793
+26% +$1.46M 4.22% 7
2021
Q1 		$5.63M Sell
473,446
-435,042
-48% -$5.01M 4.61% 8
2020
Q4 		$6.23M Sell
908,488
-183,512
-17% -$1.29M 2.88% 15
2020
Q3 		$8.09M Sell
1,092,000
-528,200
-33% -$3.41M 3.85% 9
2020
Q2 		$6.76M Sell
1,620,200
-415,140
-20% -$1.52M 2.9% 13
2020
Q1 		$5.03M Buy
2,035,340
+607,063
+43% +$2.73M 2.35% 17
2019
Q4 		$8.3M Buy
1,428,277
+638,049
+81% +$3.69M 3.64% 12
2019
Q3 		$4.17M Buy
790,228
+92,307
+13% +$497K 2.31% 17
2019
Q2 		$4.19M Buy
697,921
+114,621
+20% +$863K 2.11% 17
2019
Q1 		$5.27M Buy
583,300
+178,837
+44% +$1.52M 2.3% 15
2018
Q4 		$3.36M Buy
+404,463
New +$4.14M 1.73% 23

Other funds holding ALDX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Prosight Management's ALDX Position: Q3 2023 in Review

Prosight Management sold out of Aldeyra Therapeutics (ALDX) in Q3 2023, closing a stake of 149,511 shares — an estimated $1.25M sold.

Prosight Management first reported a position in ALDX in Q4 2018 and held it in 19 quarters. The position peaked at $8.3M in Q4 2019. 120 funds tracked by Wall St. Rank hold ALDX as of Q3 2023.

  • Prosight Management reported no remaining Aldeyra Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Prosight Management sold 149,511 Aldeyra Therapeutics shares in Q3 2023, an estimated $1.25M.
  • Prosight Management first reported a position in Aldeyra Therapeutics in Q4 2018 and held it in 19 quarters.
  • Prosight Management's Aldeyra Therapeutics position peaked at $8.3M in Q4 2019.
  • 120 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2023.

Based on Prosight Management's 13F filing for Q3 2023, filed 14 Nov 2023.